Research progress of human intravenous immunoglobulin in the treatment ofCOVID-19
10.13303/j.cjbt.issn.1004-549x.2021.05.028
- VernacularTitle:静注人免疫球蛋白在新型冠状病毒肺炎治疗中的应用
- Author:
Wei ZHANG
1
;
Jixuan XU
1
;
Zongkui WANG
1
;
Li MA
1
;
Changqing LI
1
Author Information
1. Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu 610052, China
- Publication Type:Journal Article
- Keywords:
human intravenous immunoglobulin;
COVID-19;
mechanism of action
- From:
Chinese Journal of Blood Transfusion
2021;34(5):547-556
- CountryChina
- Language:Chinese
-
Abstract:
COVID-19 has brought huge damage and impact to the economy, society and healthy systems of China and the world. As a blood product prepared from healthy human blood, human intravenous immunoglobulin have played an active role in the fight against the epidemic. This article summarized the treatment plans, expert consensus and clinical reports in China concerning immunoglobulin in the treatment of COVID-19, and discussed the related possible mechanism of action, aiming at providing references for the drugs screening of COVID-19.
